Smith & Nephew (SNN) Notes Payables (2009 - 2023)

Smith & Nephew (SNN) posted quarterly Notes Payables of -$2.0 million for Q4 2023, up 66.67% year-on-year from -$1.2 million in Q4 2022, and up 66.67% on a QoQ basis from -$6.0 million in Q4 2022.

Smith & Nephew (SNN) Notes Payables (2009 - 2023) Analysis & Trends

Smith & Nephew (SNN) has reported Notes Payables for 12 consecutive years, with -$2.0 million the latest figure, recorded in Q4 2023.

  • Quarterly Notes Payables rose 66.67% year-over-year to -$2.0 million in Q4 2023, while the trailing twelve-month figure through Dec 2023 was -$2.0 million (up 66.67% YoY) and the FY2023 annual result came in at -$2.0 million, up 66.67% from the prior year.
  • Notes Payables climbed to -$2.0 million in Q4 2023 per SNN's latest filing, from -$6.0 million in the prior quarter.
  • Over the last five years, Notes Payables for SNN reached as high as -$2.0 million in Q4 2023 and fell as low as -$6.0 million in Q4 2022.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn
9 Smith & Nephew 25.80 Bn 25.22 Bn -
10 Steris 20.59 Bn 20.16 Bn 697.10 Mn

Historic Data

Download Data
DateValue
Dec 31, 2023 -2.00 Mn
Dec 31, 2022 -6.00 Mn
Dec 31, 2018 164.00 Mn
Jun 30, 2018 86.00 Mn
Dec 31, 2017 27.00 Mn
Dec 31, 2016 86.00 Mn
Dec 31, 2015 46.00 Mn
Jun 30, 2015 66.00 Mn
Dec 31, 2014 39.00 Mn
Sep 30, 2014 91.00 Mn
Jun 28, 2014 65.00 Mn
Mar 31, 2014 61.00 Mn
Dec 31, 2013 44.00 Mn
Sep 28, 2013 69.00 Mn
Jun 29, 2013 46.00 Mn
Mar 31, 2013 54.00 Mn
Dec 31, 2012 38.00 Mn
Sep 29, 2012 53.00 Mn
Jun 30, 2012 56.00 Mn
Mar 31, 2012 268.00 Mn